LPLP
OXFD

Lansdowne Partners Limited Partnership’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Lansdowne Partners Limited Partnership’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$10.5M Hold
522,354
– – 0.09% 40
2013
Q4 		$10.1M Buy
+522,354
New +$9.24M 0.09% 32

Other funds holding OXFD

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lansdowne Partners Limited Partnership's OXFD Position: Q1 2014 in Review

Lansdowne Partners Limited Partnership held its Oxford Immunotec Global PLC Ordinary Shares (OXFD) position steady in Q1 2014 at 522,354 shares worth $10.5M. The position accounts for 0.09% of the portfolio, ranked #40.

Lansdowne Partners Limited Partnership first reported a position in OXFD in Q4 2013 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold OXFD as of Q1 2014.

  • Lansdowne Partners Limited Partnership held 522,354 shares of Oxford Immunotec Global PLC Ordinary Shares worth $10.5M as of Q1 2014.
  • Lansdowne Partners Limited Partnership left its Oxford Immunotec Global PLC Ordinary Shares share count unchanged in Q1 2014.
  • Oxford Immunotec Global PLC Ordinary Shares made up 0.09% of Lansdowne Partners Limited Partnership's portfolio in Q1 2014, its #40 holding.
  • Lansdowne Partners Limited Partnership first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and has held it in 2 quarters since.
  • 47 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2014.

Based on Lansdowne Partners Limited Partnership's 13F filing for Q1 2014, filed 14 May 2014.